Viva Biotech

Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial drug delivery to global biopharmaceutical innovators. We offer l

Viva Biotech Announced 2021 Interim Results - Voice of ASEAN

Viva Biotech Buys Back $43 Million of 1% Convertible Bonds -October 13, 2023 at 07:08 am EDT

VIVA BIOTECH HOLD Aktie (A2PH5Q

VivaVision Biotech Announces Positive To

Viva Biotech announces strategic investors with $210m investment

Viva Biotech Announced 2022 Annual Results

公司目标 - Environmental, Social and Governance (ESG) - About Us - Viva Biotech

CRO Services-CRO Services-Viva Biotech

Viva Biotech Holdings (1873) Company Information - Simply Wall St

Everything You Need to Know about Viva Biotech's First ESG Report